A potential new target for treatment of hormone refractory prostate cancer
Monday, April 6, 2009 - 11:49
in Health & Medicine
A new study identifies a protein that modifies the androgen receptor (AR) and influences its ability to regulate target genes linked with the progression of prostate cancer.